Start Date
March 31, 2013
Primary Completion Date
July 31, 2016
Study Completion Date
July 31, 2016
MA09-hRPE Cellular Therapy
A suspension of either 50,000 MA09-hRPE cells (first cohort), 100,000 MA09-hRPE cells (second cohort), 150,000 MA09-hRPE cells (third cohort) or 200,000 MA09-hRPE cells (fourth cohort) in 150 uL of BSS plus will be implanted over 1 minute in the space created.
Collaborators (1)
Ocata Therapeutics
INDUSTRY
University of California, Los Angeles
OTHER